The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Systems Biology Modeling of the Radiation Sensitivity Network: A Biomarker Discovery Platform
Open accessAbstract
Purpose The discovery of effective biomarkers is a fundamental goal of molecular medicine. Developing a systems-biology understanding of radiosensitivity can enhance our ability of identifying radiation-specific biomarkers. Methods and Materials Radiosensitivity, as represented by the Survival Fraction at 2 Gy (SF2) was modeled in 48 human cancer cell lines. We apply a linear regression algorithm that integrates gene expression with biological variables including: ras status (mut/wt), tissue of origin (TO) and p53 status (mut/wt). Results The biomarker discovery platform is a network representation of the top 500 genes identified by linear regression. This network was reduced to a 10-hub network that includes: c-Jun, HDAC1, RELA (p65 subunit of NFKB), PKC-beta, SUMO-1, c-Abl, STAT1, AR, CDK1 and IRF1. Nine targets associated with radiosensitization drugs link to the network, demonstrating clinical relevance. Furthermore, the model identifies four significant radiosensitivity clusters of terms and genes. Ras was a dominant variable in the analysis along with TO and their interaction with gene expression but not p53. Overrepresented biological pathways differed between clusters but included: DNA repair, cell cycle, apoptosis and metabolism. The c-Jun network hub was validated using a knockdown approach in 8 human cell lines representing lung, colon and breast cancers. Conclusions We developed a novel radiation-biomarker discovery platform using a systems biology modeling approach. We propose this platform will play a central role in the integration of biology into clinical radiation oncology practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Error and attack tolerance of complex networks
Albert, R., Jeong, H., & Barabási, A.-L. (2000) · Nature · doi:10.1038/35019019 · Cited by 7,534
Error and attack tolerance of complex networks
Albert, R., Jeong, H., & Barabási, A.-Ĺ. (2000) · RePEc: Research Papers in Economics · Cited by 6,469
Lethality and centrality in protein networks
Jeong, H., Mason, S. P., Barabási, A.-L., & Oltvai, Z. N. (2001) · Nature · doi:10.1038/35075138 · Cited by 5,287
Systems biology: a brief overview
Kitano, H. (2002) · Science · doi:10.1126/science.1069492 · Cited by 4,265
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
Amado, R. G., Wolf, M., Peeters, M., Van Cutsem, E., Siena, S., Freeman, D. J., Juan, T., Sikorski, R., Suggs, S., Radinsky, R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.7116 · Cited by 3,207
Gene-expression profiles predict survival of patients with lung adenocarcinoma
Beer, D. G., Kardia, S. L. R., Huang, C.-C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., et al. (2002) · Nature Medicine · doi:10.1038/nm733 · Cited by 2,025
Systems Biology and New Technologies Enable Predictive and Preventative Medicine
Hood, L., Heath, J. R., Phelps, M. E., & Lin, B. (2004) · Science · doi:10.1126/science.1104635 · Cited by 1,108
Apoptosis, p53, and tumor cell sensitivity to anticancer agents.
Brown, J. M., & Wouters, B. G. (1999) · PubMed · Cited by 771
Chemosensitivity prediction by transcriptional profiling
Staunton, J. E., Slonim, D. K., Coller, H. A., Tamayo, P., Angelo, M. J., Park, J., Scherf, U., Lee, J. K., Reinhold, W. O., Weinstein, J. N., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191368598 · Cited by 684
Self-citationMolecular classification of head and neck squamous cell carcinomas using patterns of gene expression
Chung, C. H., Parker, J. S., Karaca, G., Wu, J., Funkhouser, W. K., Moore, D., Butterfoss, D., Xiang, D., Zanation, A., Yin, X., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00112-6 · Cited by 678
Weichselbaum, R. R., Ishwaran, H., Yoon, T., Nuyten, D. S. A., Baker, S. W., Khodarev, N., Su, A. W., Shaikh, A. Y., Roach, P., Kreike, B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809242105 · Cited by 615
The role of p53 in determining sensitivity to radiotherapy
Gudkov, A. V., & Komarova, E. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc992 · Cited by 572
Fertil, B., & Malaise, E. P. (1985) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(85)90223-8 · Cited by 481
The dark side of Ras: regulation of apoptosis
Cox, A. D., & Der, C. J. (2003) · Oncogene · doi:10.1038/sj.onc.1207111 · Cited by 437
Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms
Li, N., & Karin, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13012 · Cited by 427
Molecular Staging for Survival Prediction of Colorectal Cancer Patients
Eschrich, S., Yang, I., Bloom, G., Kwong, K. Y., Boulware, D., Cantor, A., Coppola, D., Kruhøffer, M., Aaltonen, L., Orntoft, T. F., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.695 · Cited by 348
Self-citationThe role of p53 in chemosensitivity and radiosensitivity
El-Deiry, W. S. (2003) · Oncogene · doi:10.1038/sj.onc.1206949 · Cited by 337
Amundson, S. A., Do, K. T., Vinikoor, L. C., Lee, R. A., Koch-Paiz, C. A., Ahn, J., Reimers, M., Chen, Y., Scudiero, D. A., Weinstein, J. N., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2120 · Cited by 253
The impact of systems approaches on biological problems in drug discovery
Hood, L., & Perlmutter, R. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1004-1215 · Cited by 229
Prediction of Radiation Sensitivity Using a Gene Expression Classifier
Torres-Roca, J. F., Eschrich, S., Zhao, H., Bloom, G., Sung, J., McCarthy, S., Cantor, A. B., Scuto, A., Li, C., Zhang, S., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0656 · Cited by 219
Self-citationCancer BiomarkersAn Invitation to the Table
Dalton, W. S., & Friend, S. H. (2006) · Science · doi:10.1126/science.1125948 · Cited by 202
Malaise, E. P., Fertil, B., Chavaudra, N., & Guichard, M. (1986) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(86)90071-4 · Cited by 192
Repair of radiation damage to DNA
Willers, H., Dahm‐Daphi, J., & Powell, S. N. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601729 · Cited by 185
DNA repair factor XPC is modified by SUMO-1 and ubiquitin following UV irradiation.
Wang, Q.-E. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki684 · Cited by 160
Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity.
Russell, J. S., Brady, K. J., Burgan, W. E., Cerra, M. A., Oswald, K. A., Camphausen, K. A., & Tofilon, P. J. (2003) · PubMed · Cited by 157
The p53 protein family and radiation sensitivity: Yes or no?
Cuddihy, A. R., & Bristow, R. G. (2004) · Cancer and Metastasis Reviews · doi:10.1023/b:canc.0000031764.81141.e4 · Cited by 153
Combined-Modality Treatment of Solid Tumors Using Radiotherapy and Molecular Targeted Agents
Ma, B. B. Y., Bristow, R. G., Kim, J., & Siu, L. L. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.044 · Cited by 130
Peters, L. J. (1990) · Radiotherapy and Oncology · doi:10.1016/0167-8140(90)90202-8 · Cited by 124
Chemoradiotherapy: Emerging treatment improvement strategies
Milas, L., Mason, K. A., Liao, Z. X., & Ang, K. K. (2002) · Head & Neck · doi:10.1002/hed.10232 · Cited by 111
Terzoudi, T. J. G. I., Jung, T., Hain, J., & V, J. (2000) · International Journal of Radiation Biology · doi:10.1080/095530000138268 · Cited by 109
Erratum: correction: Error and attack tolerance of complex networks
Albert, R., Jeong, H., & Barabási, A.-Ĺ. (2001) · Nature · doi:10.1038/35054111 · Cited by 108
Pamment, J., Ramsay, E., Kelleher, M., Dornan, D., & Ball, K. L. (2002) · Oncogene · doi:10.1038/sj.onc.1205981 · Cited by 101
NF-κB Is Required for UV-Induced JNK Activation via Induction of PKCδ
Liu, J., Yang, D., Minemoto, Y., Leitges, M., Rosner, M. R., & Lin, A. (2006) · Molecular Cell · doi:10.1016/j.molcel.2005.12.020 · Cited by 98
Merging microarray data from separate breast cancer studies provides a robust prognostic test
Xu, L., Tan, A. C., Winslow, R. L., & Geman, D. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-125 · Cited by 97
Chen, A. Y., Okunieff, P. G., Pommier, Y. G., & Mitchell, J. B. (1997) · PubMed · Cited by 85
Caenorhabditis elegans ABL-1 antagonizes p53-mediated germline apoptosis after ionizing irradiation
Deng, X., Hofmann, E. R., Villanueva, A., Hobert, O., Capodieci, P., Veach, D. R., Yin, X., Campodonico, L., Glekas, A., Cordon‐Cardo, C., et al. (2004) · Nature Genetics · doi:10.1038/ng1396 · Cited by 80
Wang, Y., Meng, A., Lang, H., Brown, S. A., Konopa, J. L., Kindy, M. S., Schmiedt, R. A., THOMPSON, J. S., & Zhou, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0591 · Cited by 67
Fryknäs, M., Dhar, S., Oberg, F. G., Rickardson, L., Rydåker, M., Göransson, H., Gustafsson, M. G., Pettersson, U., Nygren, P., Larsson, R. L., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22291 · Cited by 65
Histone Deacetylation as a Target for Radiosensitization
Cerna, D., Camphausen, K. A., & Tofilon, P. J. (2006) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(05)73006-4 · Cited by 57
Effect of sequencing of androgen deprivation and radiotherapy on prostate cancer growth
Kaminski, J., Hanlon, A. L., Joon, D. L., Meistrich, M. L., Hachem, P., & Pollack, A. S. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00539-x · Cited by 57
Hallahan, D. E., Gius, D. R., Kuchibhotla, J., Sukhatme, V. P., Kufe, D. W., & Weichselbaum, R. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53480-3 · Cited by 56
The influence of Ras pathway signaling on tumor radiosensitivity
Kim, I. A., Fernandes, A., Gupta, A., McKenna, W. G., & Bernhard, E. J. (2004) · Cancer and Metastasis Reviews · doi:10.1023/b:canc.0000031763.95152.09 · Cited by 34
Kao, G. D., McKenna, W. G., & Muschel, R. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34779 · Cited by 20
Prolonged c-jun expression in irradiated ataxia telangiectasia fibroblasts
Hallahan, D. E., Dunphy, E., Kuchibhotla, J., Kraft, A., Unlap, T., & Weichselbaum, R. R. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00327-6 · Cited by 16
Nakajima, T., Yukawa, O., Azuma, C., Ohyama, H., Wang, B., Kojima, S., Hayata, I., & Hama-Inaba, H. (2004) · Radiation Research · doi:10.1667/rr3176 · Cited by 16
Cited by
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study
Scott, J. G., Berglund, A., Schell, M. J., Mihaylov, I., Fulp, W. J., Yue, B., Welsh, E., Caudell, J. J., Ahmed, K., Strom, T. S., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30648-9 · Cited by 474
Self-citationLiauw, S. L., Connell, P. P., & Weichselbaum, R. R. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005148 · Cited by 257
Scott, J. G., Sedor, G., Ellsworth, P., Scarborough, J. A., Ahmed, K. A., Oliver, D. E., Eschrich, S. A., Kattan, M. W., & Torres-Roca, J. F. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00347-8 · Cited by 158
Self-citationTorres-Roca, J. F. (2012) · Personalized Medicine · doi:10.2217/pme.12.55 · Cited by 81
Self-citation
Metadata
- Authors
- Eschrich, S., Zhang, H., Zhao, H., Boulware, D., Lee, J.-H., Bloom, G., & Torres-Roca, J. F.
- Venue
- International Journal of Radiation Oncology*Biology*Physics
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 75
- Issue
- 2
- Pages
- 497-505
- ISSN
- 0360-3016 (ISSN-L)
- OpenAlex
- W2050034556
- Cited by
- 276
- References
- 46
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.